Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL-USP2 fusions.,Leukemia

当前位置： X-MOL 学术 › Leukemia › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL-USP2 fusions.
Leukemia ( IF 12.8 ) Pub Date : 2019-03-21 , DOI: 10.1038/s41375-019-0451-7
Claus Meyer ₁ , Bruno A Lopes _{1,

2} , Aurélie Caye-Eude ₃ , Hélène Cavé ₃ , Chloé Arfeuille ₃ , Wendy Cuccuini ₄ , Rosemary Sutton ₅ , Nicola C Venn ₅ , Seung Hwan Oh _{1,

6} , Grigory Tsaur ₇ , Gabriele Escherich ₈ , Tobias Feuchtinger ₉ , Hansen J Kosasih ₁₀ , Seong L Khaw ₁₀ , Paul G Ekert _{5,

10} , Maria S Pombo-de-Oliveira ₁₁ , Audrey Bidet ₁₂ , Bardya Djahanschiri ₁₃ , Ingo Ebersberger _{13,

14} , Marketa Zaliova ₁₅ , Jan Zuna ₁₅ , Zuzana Zermanova ₁₆ , Vesa Juvonen ₁₇ , Renate Panzer Grümayer ₁₈ , Grazia Fazio ₁₉ , Gianni Cazzaniga ₁₉ , Patrizia Larghero ₁ , Mariana Emerenciano ₂ , Rolf Marschalek ₁

Affiliation

DCAL/Institute of Pharmaceutical Biology, Goethe-University Frankfurt, Frankfurt am Main, Germany.
Division of Clinical Research, Research Center, Instituto Nacional de Cancer, Rio de Janeiro, Brazil.
Department of Genetics, AP-HP Robert Debré, Paris Diderot University, Paris, France.
Department of Cytogenetics, Saint Louis Hospital, Paris, France.
Children's Cancer Institute Australia, University of NSW Sydney, Sydney, Australia.
Department of Laboratory Medicine, Inje University College of Medicine, Busan, Korea.
Regional Children Hospital 1, Research Institute of Medical Cell Technologies, Pediatric Oncology and Hematology Center, Ural Federal University named after the first President of Russia BN Yeltsin, Ekaterinburg, Russia.
Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner University Children's Hospital, Ludwig Maximilian University Munich, Munich, Germany.
Murdoch Children's Research Institute, The Royal Children's Hospital, Flemington Road Parkville, 3052, Victoria, Australia.
Pediatric Hematology-Oncology Program-Research Center, Instituto Nacional de Cancer Rio de Janeiro, Rio de Janeiro, Brazil.
Laboratoire d'Hématologie, University Hospital, Brest, CHU de Bordeaux, Bordeaux, France.
Department of Applied Bioinformatics, Institute of Cell Biology and Neuroscience, Goethe-Universität Frankfurt, Frankfurt am Main, 60438, Germany.
Senckenberg Climate and Research Centre (BIK-F), Frankfurt am Main, 60325, Germany.
CLIP, Department of Paediatric Haematology/Oncology, Charles University Prague, 2nd Faculty of Medicine, Prague, Czech Republic.
Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Department of Clinical Chemistry and Laboratory Division, Turku University Hospital, Turku, Finland.
Children's Cancer Research Institute, Medical University of Vienna, Vienna, Austria.
Centro Ricerca Tettamanti, Clinica Pediatrica University of Milano-Bicocca, Monza, Italy.